¥ê¥ó¥¯
¥á¥¤¥ó | ÅÐÏ¿¤¹¤ë | ¿Íµ¤¥µ¥¤¥È (top10) | ¹âɾ²Á¥µ¥¤¥È (top10) | ¤ª¤¹¤¹¤á¥µ¥¤¥È (8) | Áê¸ß¥ê¥ó¥¯¥µ¥¤¥È (3) |
¥«¥Æ¥´¥ê°ìÍ÷ | RSS/ATOM Âбþ¥µ¥¤¥È (19) | RSS/ATOM µ»ö (62344) | ¥é¥ó¥À¥à¥¸¥ã¥ó¥× |
RSS/ATOM µ»ö (62344)
¤³¤³¤Ëɽ¼¨¤µ¤ì¤Æ¤¤¤ë RSS/ATOM µ»ö¤ò RSS ¤È ATOM ¤ÇÇÛ¿®¤·¤Æ¤¤¤Þ¤¹¡£


¥¢¥ë¥Õ¥ì¥Ã¥µ»Ò²ñ¼Ò¡¢ÂÛÈפäÍÓËì¡¢çÁÂӤʤɤζ¡µë¼õ¤±¹ñ»º¤Î¾²ÈºÙ˦¸¶ÎÁ¤òÄó¶¡¤Ø from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2024-5-28 7:00) |
¡¡¥¢¥ë¥Õ¥ì¥Ã¥µ ¥Û¡¼¥ë¥Ç¥£¥ó¥°¥¹»Ò²ñ¼Ò¤Î¥»¥ë¥ê¥½¡¼¥·¥º¡ÊÅìµþ¡¦ÀéÂåÅÄ¡¢ÍÅŧÂÀϺÂåɽ¼èÄùÌò¼ÒĹ¡Ë¤Ï2024ǯ5·î27Æü¡¢¹ñΩÀ®°é°åΟ¦µæ¥»¥ó¥¿¡¼¤È¡¢¾¦ÍÑÍøÍѲÄǽ¤Ê¥Ò¥È¤Î¾²ÈÂÎÀ´´ºÙ˦¸¶ÎÁ¤Î¶¡µë¤Ë´Ø¤¹¤ë·ÀÌó¤ò2024ǯ4·î23ÆüÉÕ¤ÇÄù·ë¤·¤¿¤Èȯɽ¤·¤¿¡£ÂÛÈפäÍÓËì¡¢çÁÂӤʤɤζ¡µë¤ò¼õ¤±¤Æ¥Þ¥¹¥¿¡¼¥»¥ë¤ò¹½ÃÛ¤·¡¢¹ñ»º¤ÎºÙ˦¸¶ÎÁ¤ÎÄ󶡤òÌܻؤ¹¡£
|
±öÌîµÁ¤Î¿··¿¥³¥í¥Ê¥ï¥¯¥Á¥ó¡¢¥¢¥Ó¥¬¥ó¤ÎSFTS¥¦¥¤¥ë¥¹´¶À÷¾É¤Ø¤ÎŬ±þ¤Ê¤É¾µÇ§Î»¾µ from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2024-5-28 7:00) |
¡¡¸üÀ¸Ï«Æ¯¾Ê¤Ï2024ǯ5·î24Æü¡¢Ìô»ö¿³µÄ²ñ°åÌôÉÊÂèÆóÉô²ñ¤ò³«ºÅ¤·¤¿¡£±öÌîµÁÀ½Ìô¤Î¿··¿¥³¥í¥Ê¥¦¥¤¥ë¥¹´¶À÷¾É¡ÊCOVID-19¡Ë¥ï¥¯¥Á¥ó¡Ö¥³¥Ö¥´¡¼¥º¶ÚÃí¡×¡ÊÁÈ´¹¤¨¥³¥í¥Ê¥¦¥¤¥ë¥¹¡ÌSARS-CoV-2¡Í¥¹¥Ñ¥¤¥¯ÃÁÇò¼Á¹³¸¶¡Ë¤Ê¤É6ÉÊÌܤο·µ¬¾µÇ§¤òλ¾µ¤·¤¿Â¾¡¢ÉٻΥե¤¥ë¥àÉÙ»³²½³Ø¤Î¡Ö¥¢¥Ó¥¬¥ó¾û¡×¡Ê¥Õ¥¡¥Ó¥Ô¥é¥Ó¥ë¡Ë¤Î¸úǽ¡¦¸ú²Ì¤Ë¡¢½Å¾ÉÇ®À·ì¾®Èĸº¾¯¾É¸õ·²¡ÊSFTS¡Ë¥¦¥¤¥ë¥¹´¶À÷¾É¤òÄɲ乤ë¤Ê¤É¤Î°ìÉôÊѹ¹¿½ÀÁ¤âλ¾µ¤µ¤ì¤¿¡£
|
ÊÆCircular Genomics¼Ò¡¢¤¦¤ÄÉ´µ¼Ô¤ÎSSRI¤Ø¤ÎÈ¿±þͽ¬¤¹¤ëcircRNA¥Þ¡¼¥«¡¼¤ò³«È¯ from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2024-5-27 7:00) |
¡¡ÀºÌ©Àº¿À°å³Ø/¿À·Ð³Ø¤Î¤¿¤á¤Î´Ä¾õRNA¡ÊcircRNA¡Ë¥Ð¥¤¥ª¥Þ¡¼¥«¡¼¤ÎÎΰè¤ÇÀ¤³¦¤ò¸£°ú¤¹¤ëÊÆCircular Genomics¼Ò¤Ï¡¢2024ǯ5·î7Æü¡¢circRNA¥Þ¡¼¥«¡¼¤ò¸¡½Ð¤¹¤ëPCR¥Ù¡¼¥¹¤Î·ì±Õ¸¡ºº¤¬¡¢¥»¥ë¥È¥é¥ê¥ó¤ò¤Ï¤¸¤á¤È¤¹¤ëÁªÂò¼°¥»¥í¥È¥Ë¥óºÆ¼è¤ê¹þ¤ßÁ˳²Ìô¡ÊSSRI¡Ë¤ËÂФ¹¤ëÂ礦¤ÄÉ´µ¼Ô¤ÎÈ¿±þ¤òͽ¬¤Ç¤¤ë¤³¤È¤ò¼¨¤·¤¿EMBARC¸¦µæ¤Î·ë²Ì¤òȯɽ¤·¤¿¡£Æ±¸¦µæ¤Ë´Ø¤¹¤ëººÆÉÁ°ÏÀʸ¤ÏbioRXiv¤ËƱǯ5·î1Æü¤Ë¸ø³«¤µ¤ì¤¿¡£
|
ÃÁÇò¼Á¤ÎưÂÖ²òÀϤΥâ¥ë¥ß¥ë¡¢Ä´Ã£»ñ¶â¤ÇÆàÎɸ©Î©°åÂç¤Ë¶¦Æ±¸¦µæ¹ÖºÂ¤òÀßÃÖ from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2024-5-27 7:00) |
¡¡Ê¬Àϲ½³ØÅª¼êË¡¤È³Ë¼§µ¤¶¦ÌÄË¡¡ÊNMR¡Ë¤òÍѤ¤¤ÆÃÁÇò¼Á¤ÎưÂÖ¤ò²òÀϤ¹¤ëÁÏÌô´ðÈ×µ»½Ñ¤ò³«È¯¤¹¤ë¥¹¥¿¡¼¥È¥¢¥Ã¥×¤Î¥â¥ë¥ß¥ë¡ÊÆàÎɸ©³à¸¶»Ô¡¢¿¹±Ñ°ìϯÂåɽ¼èÄùÌò¡Ë¤Ï2024ǯ5·î24Æü¡¢¥·¡¼¥É¥é¥¦¥ó¥É¤ÇÂè»°¼Ô³äÅöÁý»ñ¤Ë¤è¤ë»ñ¶âĴã¤ò¼Â»Ü¤·¤¿¤Èȯɽ¤·¤¿¡£º£²ó¤Î»ñ¶âĴã¤Ë¤è¤ê¡¢ÆàÎɸ©Î©°å²ÊÂç³Ø¤Ë¶¦Æ±¸¦µæ¹ÖºÂ¤òÀßÃÖ¤·¡¢ÁÏÌô´ðÈ×µ»½Ñ¤Î³ÎΩ¤ò¿Ê¤á¤ë¡£
|
³¤ÍÎÂ硦µÈºê¶µ¼ø¡¢¡Ö¥Ë¥¸¥Þ¥¹¤Ë¥µ¥±¤ò»º¤Þ¤»¤ë¡×¤³¤È¤ËÀ®¸ù from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2024-5-27 7:00) |
¡¡Åìµþ³¤ÍÎÂç³Ø³Ø½Ñ¸¦µæ±¡³¤ÍÎÀ¸Êª»ñ¸»³ØÉôÌç¤ÎµÈºê¸çϯ¶µ¼ø¤é¤Î¸¦µæ¥Á¡¼¥à¤Ï¡¢À¸¿£´´ºÙ˦¤ò°Û¼ï´Ö¤Ç°Ü¿¢¤¹¤ëÂåÍý¿Æµûµ»Ë¡¤ò³èÍѤ·¡¢¥µ¥±¤ÎÍñ¤ò¥Ë¥¸¥Þ¥¹¤Ë»º¤Þ¤»¤ë¤³¤È¤ËÀ®¸ù¤·¤¿¤Èȯɽ¤·¤¿¡£¥µ¥±Îà¤Î¿¤¯¤Ï»ºÍñ¤ò½ª¤¨¤ë¤È»à¤ó¤Ç¤·¤Þ¤¦¤¬¡¢¥Ë¥¸¥Þ¥¹¤òÂåÍý¿Æµû¤Ë¤¹¤ë¤È»ºÍñ¤·¤Æ¤â¿Æµû¤¬»à¤Ê¤º¡¢1¸ÄÂΤ˷«¤êÊÖ¤·»ºÍñ¤ò¤µ¤»¤ë¤³¤È¤¬¤Ç¤¤ë¤È¤¤¤¦¡£ÏÀʸ¤Ï2024ǯ5·î24Æü¡ÊÊÆ¹ñ»þ´Ö¡Ë¡¢Science Advances»ï¤Ë·ÇºÜ¤µ¤ì¤¿¡£
|
¾ÃÈñ¼ÔÄ£¤Î¸¡Æ¤²ñ¡¢¹È¹íÌäÂê¼õ¤±µ¡Ç½Àɽ¼¨¿©Éʤε¬À©¤Ë¤Ä¤¤¤ÆÄó¸À°Æ from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2024-5-27 7:00) |
¡¡¾®ÎÓÀ½Ìô¤¬À½Â¤¤¹¤ëÆÈ¼«¤Î¹È¹í¸¶ÎÁ¤ò´Þ¤àµ¡Ç½Àɽ¼¨¿©ÉÊ¡Ö¹È¹í¥³¥ì¥¹¥Æ¥Ø¥ë¥×¡×¤òÀݼ褷¤¿¿Í¤Ë·ò¹¯Èï³²¤¬½Ð¤Æ¤¤¤ëÌäÂê¤ò¼õ¤±¡¢¾ÃÈñ¼ÔÄ£¤Î¡Öµ¡Ç½Àɽ¼¨¿©Éʤò½ä¤ë¸¡Æ¤²ñ¡×¤¬Êó¹ð½ñ°Æ¤ò¤Þ¤È¤á¤¿¡£µ¡Ç½Àɽ¼¨¿©ÉÊÀ©Å٤βÝÂê¤Èº£¸å¤ÎÂкö¤Ë¤Ä¤¤¤Æ¡¢À¯Éܤ¬¼è¤ë¤Ù¤Âбþºö¤ÎÄó¸À°Æ¤¬´Þ¤Þ¤ì¤Æ¤¤¤ë¡£2024ǯ5·î23Æü¤Ë³«ºÅ¤µ¤ì¤¿Âè6²ó¸¡Æ¤²ñ¤ÇÊó¹ð½ñ°Æ¤ÎÆâÍÆ¤òÄ󼨤·¤¿¡£
|
Endpoints News¡¢Vertex¼Ò¤¬³ÍÆÀ¤·¤¿Alpine¼Ò¤ÎIgA¿Õ¾É¼£ÎÅÌô¸õÊä¤Ï¡Ö¥Ò¥å¥ß¥é¡×ƱÍͤβÄǽÀÈë¤á¤ë¤âŬ±þ¾ from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2024-5-27 7:00) |
¡¡ÊÆVertex Pharmaceuticals¡Ê¥Ð¡¼¥Æ¥Ã¥¯¥¹¡¦¥Õ¥¡¡¼¥Þ¥·¥å¡¼¥Æ¥£¥«¥ë¥º¡Ë¼Ò¤Î¡Ö1À½ÉʤÇÊ£¿ô¤Î¥Ñ¥¤¥×¥é¥¤¥ó¡Ê¡Èpipeline-in-a-product¡É¡Ë¡×¤ò¹½ÃÛ¤¹¤ë¤â¤¯¤í¤ß¤ÏÊó¤ï¤ì¤ë¤À¤í¤¦¤«¡©
|
¥Ù¥ó¥Á¥ã¡¼ÃµË¬¡¢GramEye¡¢AI¤Ë¤è¤ëÈùÀ¸Êª¸¡ºº¥·¥¹¥Æ¥à¤ò°åÎŵ¡´ï¤È¤·¤Æ³«È¯Ãæ from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2024-5-27 7:00) |
¡¡GramEye¡ÊÂçºåÉܰñÌÚ»Ô¡¢Ê¿²¬ÍªÂåɽ¼èÄùÌòCEO¡Ë¤Ï¡¢¥°¥é¥àÀ÷¿§¤Ë¤è¤ëÈùÀ¸Êª¸¡ºº¤ò¼«Æ°²½µ¡´ï¤È¿Í¹©ÃÎǽ¡ÊAI¡Ë¤Ë¤è¤Ã¤Æ¼Â»Ü¤¹¤ë¥·¥¹¥Æ¥à¤ò¡¢°åÎŵ¡´ï¤È¤·¤Æ³«È¯¤·¤Æ¤¤¤ë¡£
|
2024ǯ5·î27Æü¹æ¡¡Ìܼ¡ from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2024-5-27 6:59) |
|
¥Ñ¥¤¥×¥é¥¤¥ó¸¦µæ¡ý°ß¤¬¤ó¼£ÎÅÌô¡Ú³«È¯Æ°¸þÊÔ¡Û¡¢¥ª¥×¥¸¡¼¥Ü¤È¥¥¤¥È¥ë¡¼¥À¤¬¶¥¤¦°ß¤¬¤ó¼£ÎÅÌô¡¢Âè°ì»°¶¦¤ä from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2024-5-27 6:55) |
¡¡ÆüËܤǤϡ¢2022ǯ¤Ë°ß¤¬¤ó¤Ç»àË´¤·¤¿´µ¼Ô¿ô¤¬Á°Ç¯ÅÙ¤«¤é900¿Í°Ê¾å¸º¤ë¤Ê¤É¡¢¸º¾¯·¹¸þ¤Ë¤¢¤ë¡£HER2±¢À°ß¤¬¤ó¤Ç¤Ï¡Ö¥¥¤¥È¥ë¡¼¥À¡×¤¬¡Ö¥ª¥×¥¸¡¼¥Ü¡×¤Ë³¤¡¢2023ǯ4·î¤ËÊÆ¹ñ¤Ç¾µÇ§¤ò¼èÆÀ¤·¤¿¡£Âè°ì»°¶¦¤Ï2020ǯ¤«¤é2022ǯ¤Ë¤«¤±¤Æ¡¢ADC¤Ç¤¢¤ë¡Ö¥¨¥ó¥Ï¡¼¥Ä¡×¤ÎHER2ÍÛÀ°ß¤¬¤ó¤Î2¼¡¤«¤é3¼¡¼£ÎŤˤĤ¤¤Æ¡¢ÆüËܤȲ¤ÊƤǾµÇ§¤ò¼èÆÀ¤·¤¿¡£º£¸å¤âŬ±þ³ÈÂç¤òÌܻؤ¹¡£¥¢¥¹¥Æ¥é¥¹À½Ìô¤Î¹³CLDN18.2 ¹³ÂÎ¡Ö¥Ó¥í¥¤¡×¤¬2024ǯ3·î¡¢À¤³¦¤ËÀè¶î¤±¤ÆÆüËܤǾµÇ§¤µ¤ì¤¿¡£
|